Anti-CD44 antibody [EPR18668] (Ab189524)
CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I
详细信息
背景信息
What is this antibody validated in? Anti-CD44 antibody [EPR18668] (ab189524) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples. What is the molecular weight of CD44? Anti-CD44 [EPR18668] (ab189524) specifically detects a band for CD44 (UniProt: P16070) at a molecular weight of 82kDa. Trusted by the scientific community Anti-CD44 [EPR18668] (ab189524) was first used in a scientific publication in 2017 and has been cited over 70 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-CD44 antibody [EPR18668] (ab189524) has been confirmed by Western blot testing in CD44 Knockout HeLa cells. Other related products We have a range of other formats of antibody clone [EPR18668] also available for your convenience: ab189524, Carrier free - ab232556, Alexa Fluor® 488 - ab284640, Alexa Fluor® 647 - ab314280 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (133)
Degradable scaffold-mediated synergistic matrix formation by endogenous cells: an in vivo manufacturing strategy for off-the-shelf vascular grafts to address clinical shortages.
可降解支架介导的内源细胞协同基质形成:一种用于解决临床短缺的现成血管移植物体内制造策略。
Dysregulated hyaluronan metabolism drives inflammation and angiogenesis in proliferative diabetic retinopathy.
透明质酸代谢失调驱动增殖性糖尿病视网膜病变中的炎症和血管生成。
Glioblastoma In Vitro Model That Recapitulates the Influence of the Hyaluronan Molecular Weight in Cancer Cell Motility and Permeability of the Blood-Brain Tumor Barrier.
胶质母细胞瘤体外模型重现了透明质酸分子量对癌细胞运动性和血脑肿瘤屏障通透性的影响。
Disruption of proteoglycan 4 (PRG4)-CD44 signaling modulates chronic synovitis in conditionally inactivated mice.
蛋白聚糖 4 (PRG4)-CD44 信号传导的破坏会调节条件性失活小鼠的慢性滑膜炎。
Knock-down of the long isoform of the WNK1 kinase mitigates the anti-glomerular basement membrane glomerulonephritis in mice.
敲除 WNK1 激酶的长亚型可减轻小鼠的抗肾小球基底膜肾小球肾炎。
Integrative analysis of non-small cell lung cancer identifies Jumonji domain-containing 6/ETS homologous factor axis as a target to overcome radioresistance.
对非小细胞肺癌的综合分析发现,含 Jumonji 结构域 6/ETS 同源因子轴是克服放射抗性的靶点。
Subaqueous acoustic pressure system based one day heterotypic pseudo-islet spheroid formation with adipose derived stem cells for graft survival-related function enhancement.
基于水下声压系统,利用脂肪来源干细胞在一天内形成异型假胰岛球体,以增强移植存活相关的功能
Metabolism archetype cancer cells induce protumor TREM2(+) macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma.
代谢原型癌细胞通过oxLDL介导的代谢相互作用诱导肝细胞癌中的促肿瘤TREM2(+)巨噬细胞
A novel biomimetic nanoplatform amplifies ferroptosis for specific cGAS-STING pathway activation to enhance hepatocellular carcinoma chemo-immunotherapy.
一种新型仿生纳米平台可放大铁死亡,从而激活特定的 cGAS-STING 通路,以增强肝细胞癌的化疗免疫疗法。
18F-5-fluoro-aminosuberic acid PET/CT imaging of oxidative-stress features during the formation of DEN-induced rat hepatocellular carcinoma
18F-5-氟氨基辛二酸 PET/CT 成像显示 DEN 诱发的大鼠肝细胞癌形成过程中的氧化应激特征
- 1
- 2
- 3
- 4
- 5
- 6
- 14